Power Law company profile

Sierra Oncology

Biotech & Life Sciences · San Mateo, United States · Founded 2004 · IPO 2015 Unicorn

Targeted Cancer Therapies using DNAi

Valuation

$1.90B

Market cap · 2026

Revenue

$300K

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

14 investors on Sierra Oncology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Apjohn ventures

Series A 1 investor entered at this stage

Orchard Venture Partners

Series B+ 12 investors entered at this stage

Hopen Life Science Ventures

RA Capital Management

OrbiMed

Michigan Economic Development Corporation

Adams Street Partners

Janus Capital Group

The Amherst Fund

Grand Angels

Sectoral Asset Management

Capital Midwest Fund

Frazier Healthcare Partners

Vivo Capital

Global footprint

Where Sierra Oncology has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Market sentiment

What the market is saying about Sierra Oncology

An AI-synthesized read of the highest-engagement posts about Sierra Oncology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sierra Oncology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles